XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Collaborative Arrangements - Eisai Co., Ltd. - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Sep. 30, 2024
Alliance revenue - Lenvima | Licenses and Other        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Finite-lived intangible assets       $ 502,000,000
Eisai        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Amortization of intangible assets $ 81,000,000   $ 154,000,000  
Eisai | Alliance revenue - Lenvima | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Probable contingent payments 125,000,000 $ 125,000,000    
Liabilities $ 250,000,000   $ 250,000,000  
Eligible future contingent sales-based milestone payments (up to)       2,300,000,000
Eligible future contingent regulatory milestone payments (up to)       0
Bayer AG | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Eligible future contingent sales-based milestone payments (up to)       $ 0